Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MindBio Therapeutics Corp
C.MBIO
Healthcare
Biotechnology
MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its...
drug and technology protocols through clinical trials. It develops a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants and has completed a Phase 2a clinical trial in patients with Major Depressive Disorder. The underway are two Phase 2B trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. It invests in research that forms the basis for developing novel and clinically proven treatments.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MBIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(8)
•••
RocketRed777
X
View Profile
View Bullboard History
Post by
RocketRed777
on May 14, 2024 9:53am
ENVERIC BIOSCIENCES SIGNS $66.5 MILLION
Mindbio signs term sheet for Enveric psilocin prodrugs 2024-05-14 09:35 ET - News Release Shares issued 135,047,305 MBIO Close 2024-05-13 C$ 0.055 Mr. Justin Hanka reports
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 14, 2024 8:11am
New Press Release - Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of...
read article.
GameSquare Holdings Reports Record 2024 Third Quarter Results
posted Nov 15, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Justin Kenna, CEO of GameSquare, stated, "GameSquare delivered strong third quarter financial results that were in line with our pre-announcement, and reflect the strategies underway to drive organic sales growth, complete the integration of our recent acquisitions, and build a profitable organization. On a sequential basis, I am encouraged by the ...read more
(744)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 14, 2024 7:02am
Interim Financials MD&A
https://www.sedarplus.ca/csa-party/viewInstance/resource.html?node=W2713&drmKey=f15a810d73e220dc&drr
...more
(744)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 06, 2024 9:18pm
Grant Money
The following is a link identifying the source of some of the money that was used to kickstart the current study on the benefits of microdosing LSD for advanced stage cancer patients. https://www.hrc
...more
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Post by
Sleepydog24
on May 03, 2024 1:04pm
Nazdaq
If I were Justin I'd approach the same group that took MindMed to the Naz ... they've been very successful very liquid and very much in the investor line of sight always ... this sideways
...more
(744)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 03, 2024 11:34am
RE:RE:Where does the money come from?
Absolutely true, Sleepydog! Mindbend has been at this for a little over 4 years which would explain the "current" difference in market cap. Being an American entity where 95% of their
...more
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Post by
Sleepydog24
on May 03, 2024 12:40am
Doctors and Scientists
The group of Doctors and Scientists behind this have simply amazing backgrounds and track records ... as Smoky said the money is being put forward through grants and other areas because of the
...more
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Comment by
Sleepydog24
on May 03, 2024 12:31am
RE:Where does the money come from?
Amazing info you provide Smoky ... I feel this is going to be trading on the Naz and be the twin of MindMed which is close to a $Billion marketcap Canadian... both at the same stages in clinical
...more
(744)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 02, 2024 10:44am
Where does the money come from?
MBIO has to have significant research connections to move forward as quickly as they have been in branching out from Phase 1 to Phase 2 trials and already forecasting Phase 3 trials. The researchers
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 02, 2024 4:01am
New Press Release - MindBio Therapeutics Scientists Present Landmark Women's Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
VANCOUVER, BC / ACCESSWIRE / May 2, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a clinical stage biopharma company pioneering microdosing treatments for mental health conditions showcases Dr Rachael Sumner, presenting MindBio's landmark women's...
read article.
(744)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 01, 2024 10:16pm
RE:CEO
I'll add another of the following to the latest naysayer on CEO: * liabilities will ALWAYS be higher than assets for a startup that has yet to make revenue. Junior mining companies have
...more
(744)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 01, 2024 4:02pm
CEO
To the naysayers on MBIO CEO ....you know who you are! * LSD has four isomers so already you're dealing with different forms * proprietary can and does involve the process not just the end result
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 01, 2024 5:21am
New Press Release - MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3
VANCOUVER, BC / ACCESSWIRE / May 1, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to announce that it has been presenting MindBio to various parties, institutional investment firms and brokerage firms for a potential dual listing on a senior...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 30, 2024 6:06am
New Press Release - MindBio Therapeutics Announces Landmark Women's Health CNS Drug Trials
ASSESSING THE EFECTS OF MICRODOSING MB22001 IN MENSTRUATING PERSONS WITH AND WITHOUT PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHORIC DISORDER Multiple clinical trials in women's health approved for take-home use of MB22001MB22001 aims to address huge unmet need in the ~25% of women experiencing...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 23, 2024 12:22am
New Press Release - MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
MindBio scientist's sleep research published in prestigious peer reviewed scientific journalMindBio's proprietary treatment protocol using MB22001, results in longer sleep and better quality of sleep the day after microdosingVANCOUVER, BC / ACCESSWIRE / April 23, 2024 / MindBio Therapeutics Corp....
read article.
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.